HOXA9 and leukemia: RNA-seq analysis of A485-treated K/C-III leukemia cells further revealed significant downregulation of key hematopoietic factors, including Hoxa9, Hoxa10, Meis1, Cd34, c-Kit, and Csf1r (Fig. 6I; Additional file 2: Table S4).